Predicting potential SARS-CoV-2 spillover and spillback in animals

Zi Hian Tan,Kian Yan Yong,Jian-Jun Shu

DOI: https://doi.org/10.1016/j.jmii.2024.01.002

2024-08-19

Abstract:The COVID-19 pandemic is spreading rapidly around the world, causing countries to impose lockdowns and efforts to develop vaccines on a global scale. However, human-to-animal and animal-to-human transmission cannot be ignored, as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can spread rapidly in farmed and wild animals. This could create a worrying cycle of SARS-CoV-2 spillover from humans to animals and spillback of new strains back into humans, rendering vaccines ineffective. This study provides a key indicator of animals that may be potential susceptible hosts for SARS-CoV-2 and coronavirus infections by analysing the phylogenetic distance between host angiotensin-converting enzyme 2 and the coronavirus spike protein. Crucially, our analysis identifies animals that are at elevated risk from a spillover and spillback incident. One group of animals has been identified as potentially susceptible to SARS-CoV-2 by harbouring a parasitic coronavirus spike protein similar to the SARS-CoV-2 spike protein. These animals may serve as amplification hosts in spillover events from zoonotic reservoirs. Tracing interspecies transmission in multi-host environments based solely on in vitro and in vivo examinations of animal susceptibility or serology is a time-consuming task. This approach allows rapid identification of high-risk animals to prioritize research and assessment of the risk of zoonotic disease transmission in the environment. It is a tool to rapidly identify zoonotic species that may cause outbreaks or participate in expansion cycles of coexistence with their hosts. This prevents the spread of coronavirus infections between species, preventing spillover and spillback incidents from occurring.

Populations and Evolution

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to predict the potential transmission risks of SARS - CoV - 2 from humans to animals and from animals back to humans. Specifically, by analyzing the phylogenetic distance between the host's angiotensin - converting enzyme 2 (ACE2) and the coronavirus spike protein, researchers identify animal species that may become hosts infected by SARS - CoV - 2. This research aims to quickly identify high - risk animals for prioritizing research and evaluating the risks of cross - species disease transmission, thereby preventing the emergence and spread of new SARS - CoV - 2 variants and reducing the virus - jumping events (i.e., "spillover" and "back - spillover") between different species.

### Main research methods
1. **Data collection**: Obtain 225 ACE2 amino acid sequences (covering 130 unique species) from the Uniprot and NCBI databases.
2. **Sequence alignment and phylogenetic tree generation**: Use MAFFT for ACE2 sequence alignment, use IQ - TREE to generate a phylogenetic tree, and calculate the phylogenetic distance through the TreeSwift package.
3. **Analysis of the relationship between ACE2 and spike protein**: Analyze the phylogenetic distance between animal ACE2 and the SARS - CoV - 2 spike protein to predict potentially susceptible animals.

### Research results
- **ACE2 distance of susceptible animals**: The ACE2 distances of all known SARS - CoV - 2 - susceptible animals are less than 0.41.
- **High - risk animals**: By analyzing the phylogenetic distances of ACE2 and spike protein, some potentially high - risk animals are identified. The ACE2 distances of these animals are close to that of humans, and the carried coronavirus spike proteins are similar to those of SARS - CoV - 2.
- **List of potentially susceptible animals**: List some potentially susceptible animals based on ACE2 distances less than 0.5, such as gibbons, gorillas, chimpanzees, orangutans, etc.

### Conclusion
This research provides a method for quickly identifying high - risk animals, which is helpful for prioritizing research and evaluation, preventing the transmission of SARS - CoV - 2 between different species, and reducing the risks of the emergence and spread of new variants. This not only helps to control the epidemic but also can provide important references for future cross - species disease transmissions.